Neogenomics, Inc.
NEO
$6.45
-$0.155-2.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 163.69M | 358.08M | 386.84M | 387.81M | 387.86M |
| Total Receivables | 153.63M | 152.31M | 150.64M | 152.83M | 148.08M |
| Inventory | 34.17M | 29.77M | 26.75M | 24.46M | 23.21M |
| Prepaid Expenses | 22.83M | 22.98M | 20.17M | 18.24M | 17.40M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 18.24M | 10.79M | 11.62M | 6.91M | 7.66M |
| Total Current Assets | 392.55M | 573.93M | 596.02M | 590.24M | 584.20M |
|
|
|||||
| Total Current Assets | 392.55M | 573.93M | 596.02M | 590.24M | 584.20M |
| Net Property, Plant & Equipment | 168.33M | 167.41M | 173.69M | 174.48M | 175.83M |
| Long-term Investments | 524.14M | 522.77M | 522.77M | 522.77M | 522.77M |
| Goodwill | 524.14M | 522.77M | 522.77M | 522.77M | 522.77M |
| Total Other Intangibles | 301.80M | 331.32M | 339.68M | 348.04M | 356.40M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.13M | 6.01M | 5.89M | 5.58M | 4.08M |
| Total Assets | 1.39B | 1.60B | 1.64B | 1.64B | 1.64B |
|
|
|||||
| Total Accounts Payable | 27.49M | 16.21M | 21.61M | 16.51M | 17.19M |
| Total Accrued Expenses | 67.04M | 58.12M | 75.07M | 75.16M | 68.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.05M | 204.21M | 204.16M | 204.14M | 203.65M |
| Total Finance Division Other Current Liabilities | 1.54M | 1.16M | 409.00K | 589.00K | 972.00K |
| Total Other Current Liabilities | 1.54M | 1.16M | 409.00K | 589.00K | 972.00K |
| Total Current Liabilities | 100.12M | 279.70M | 301.24M | 296.41M | 289.96M |
|
|
|||||
| Total Current Liabilities | 100.12M | 279.70M | 301.24M | 296.41M | 289.96M |
| Long-Term Debt | 341.10M | 340.71M | 340.34M | 339.96M | 339.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 66.62M | 59.86M | 60.84M | 62.17M | 63.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 32.08M | 32.89M | 33.28M | 34.37M | 34.56M |
| Total Liabilities | 539.91M | 713.16M | 735.70M | 732.90M | 727.39M |
|
|
|||||
| Common Stock & APIC | 1.25B | 1.24B | 1.23B | 1.22B | 1.21B |
| Retained Earnings | -396.80M | -351.70M | -325.78M | -310.46M | -292.76M |
| Treasury Stock & Other | 29.00K | -56.00K | -206.00K | -643.00K | -1.02M |
| Total Common Equity | 854.04M | 888.27M | 902.34M | 908.21M | 915.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 854.04M | 888.27M | 902.34M | 908.21M | 915.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 854.04M | 888.27M | 902.34M | 908.21M | 915.88M |
|
|
|||||